HBL - Hadasit Bio-Holdings Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
HDST
IL0010954050
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.43M 1.95M 156M |
---|---|---|---|---|---|
Net income 2022 | -31M -8.14M -651M | Net income 2023 | -29M -7.62M -609M | EV / Sales 2022 | - |
Net cash position 2022 | 12.93M 3.4M 272M | Net cash position 2023 | 6.46M 1.7M 136M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.46
x | P/E ratio 2023 |
-0.25
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25% |
Managers | Title | Age | Since |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 19/09/15 |
Tamar Raz
CHM | Chairman | 60 | 17/05/14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 30/08/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 28/07/18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 04/07/16 |
Orit Stav
BRD | Director/Board Member | 53 | 31/10/17 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |